Clinical Trial Update: 4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial comparing Albuterol-HFA with Proventil-HFA was terminated; the update notes a 4-week study focusing on efficacy, safety, and pharmacokin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol-HFA (albuterol)
• Proventil-HFA (albuterol)

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma | Phase 3 | Status: TERMINATED